美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=BRIXADI"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
BRIXADI 210136 001 NDA BUPRENORPHINE SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 8MG/0.16ML (50MG/ML) Yes No 2023/05/23 2023/05/23 BRAEBURN Prescription
BRIXADI 210136 002 NDA BUPRENORPHINE SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 16MG/0.32ML (50MG/ML) Yes No 2023/05/23 2023/05/23 BRAEBURN Prescription
BRIXADI 210136 003 NDA BUPRENORPHINE SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 24MG/0.48ML (50MG/ML) Yes No 2023/05/23 2023/05/23 BRAEBURN Prescription
BRIXADI 210136 004 NDA BUPRENORPHINE SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 32MG/0.64ML (50MG/ML) Yes No 2023/05/23 2023/05/23 BRAEBURN Prescription
BRIXADI 210136 005 NDA BUPRENORPHINE SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 64MG/0.18ML (356MG/ML) Yes No 2023/05/23 2023/05/23 BRAEBURN Prescription
BRIXADI 210136 006 NDA BUPRENORPHINE SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 96MG/0.27ML (356MG/ML) Yes No 2023/05/23 2023/05/23 BRAEBURN Prescription
BRIXADI 210136 007 NDA BUPRENORPHINE SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 128MG/0.36ML (356MG/ML) Yes Yes 2023/05/23 2023/05/23 BRAEBURN Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database